7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Progressive multifocal leukoencephalopathy (PML)
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions | BMC Neurology | Full Text
Updated recommendations to minimise the risk of the rare brain infection PML with Tecfidera
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease | Nature Reviews Neurology
Progressive multifocal leukoencephalopathy | Radiology Reference Article | Radiopaedia.org
Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review - Yukitake - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
FDA Drug Safety Communication for Tecfidera (dimethyl fumarate)
Date: 25th November 2015 Subject: Tecfidera® (dimethyl fumarate): new measures to minimise the risk of PML –enhanced monitori
A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence - Martin Diebold, Valerian Altersberger, Bernhard F Décard, Ludwig Kappos, Tobias Derfuss, Johannes Lorscheider, 2019
Tecfidera (dimethyl fumarate): Progressive Multifocal Leukoencephalopathy ( PML) has occurred in a patient with severe and prolon
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction” | The Egyptian Journal of Neurology, Psychiatry and ...
PML during dimethyl fumarate treatment of multiple sclerosis: how does lymphopenia matter? - Munich Cluster for Systems Neurology - LMU Munich
Frontiers | Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
PML Reported in Ocrelizumab-Treated MS Patient | MedPage Today
Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis (26.12.2016)
Biogen Reports Another Tecfidera PML Case | MedPage Today
Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review - Yukitake - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Natalizumab Treatment Reduced Disability With No Cases of PML in Anti-JC-Virus Antibody Negative Multiple Sclerosis - Practical Neurology
1 Tecfidera® (dimethyl fumarate): Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (
PML
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease | Nature Reviews Neurology
